Grifols, S.A. GIKLY
5.55 USD 0.00 (+0.00%)
At closeNov 4, 2026, 4:00 PM EST
5.77 Day range 5.77
5.06 52-week range 6.85
- YTD
- -9.90%
- 1 year
- -18.98%
- Market cap
- 7.55B
- EPS (ttm)
- 0.41
- P/E ratio
- 13.54
- YTD return
- -9.90%
- 1-year return
- -18.98%
- Volume
- 4
- Avg volume
- 45
- Open
- 5.77
- Previous close
- 5.55
- Day's range
- 5.77 – 5.77
- 52-week range
- 5.06 – 6.85
- Earnings date
- Nov 10, 2026
2Y -0.29 (-4.97%)
Next earnings
Nov 10, 2026
Expected Nov 10, 2026. Consensus EPS estimate 0.1426.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 10, 2026 | Sep 30, 2026 | 0.1426 | — | — | — |
| Jul 28, 2026 | Jun 30, 2026 | 0.1321 | 0.1256 | -0.01 | -4.92% |
| May 7, 2026 | Mar 31, 2026 | 0.08063 | 0.08656 | +0.01 | +7.35% |
| Feb 26, 2026 | Dec 31, 2025 | 0.1481 | 0.1446 | 0.00 | -2.36% |
| Nov 4, 2025 | Sep 30, 2025 | 0.1208 | 0.1093 | -0.01 | -9.52% |
| Aug 1, 2025 | Jun 30, 2025 | 0.1128 | 0.1001 | -0.01 | -11.26% |
News
Grifols: Plasma, Profits, And Recovery Gathering Momentum 
Grifols, S.A. (GIKLY) Q3 2026 Earnings Call Transcript 
Oakmark International Small Cap Strategy Q2 2026 Portfolio Update 
Grifols, S.A. (GIKLY) Q2 2026 Earnings Call Transcript 
Grifols: Operational Recovery And Balance Sheet Improvement Support A Return To Buy (Rating Upgrade) 
Grifols Launches FESILTY™ (fibrinogen, human-chmt) in the U.S. 
Grifols, S.A. (GIKLY) Q1 2026 Earnings Call Transcript
Your note
Sign in to keep a note on GIKLY — it syncs with the Stock Master app.